Month: <span>January 2019</span>

Home / 2019 / January
Post

Certain antibiotics may cause aortic aneurysm, FDA warns

(CNN)The US Food and Drug Administration warned on Thursday that the benefits of fluoroquinolone antibiotics do not outweigh the risks — which include aortic aneurysm — for certain patients, according to the latest research. The research is based on reports of patient problems and on studies published between 2015 and 2018. Fluoroquinolone antibiotics are often...

Post

Blood pressure medication recalled due to ‘unexpected impurity’

According to the FDA (United States Food and Drug Administration), Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, (FDA) (WBTV) – A pharmaceutical company has issued a voluntary recall of blood pressure medicationThursday. According to the FDA (United States Food and Drug Administration), Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets,...

Post

Statins are more effective for those who follow the Mediterranean diet

A diet based on Mediterranean principles enhances the effect of these drugs in patients who already had a heart attack or stroke ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED I.R.C.C.S. For those who have already had a heart attack or a stroke, the combination of statins and Mediterranean Diet appears to be the most effective choice to reduce the risk of mortality,...

Post

Two Commonly Prescribed Type 2 Diabetes Drugs Raise Risk For Heart Attack

Two drugs that doctors commonly prescribe for patients with type 2 diabetes carry an increased risk of cardiovascular events such as stroke, heart attack, heart failure, and even amputation. Sulfonylureas And Basal Insulin Matthew O’Brien, from Northwestern University Feinberg School of Medicine, warned diabetes patients to be aware of medications they take in case these could lead...

Post

FDA approves drugs for treatment of two rare blood diseases

(HealthDay)—Two drugs have been approved by the U.S. Food and Drug Administration for the treatment of rare blood diseases, the agency announced Friday. Elzonris (tagraxofusp-erzs) infusion was granted the first approval for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children aged 2 years and older. Researchers investigated the efficacy of...

Post

Brain activity predicts fear of pain

Neuroscientific approach may help reconcile self-reported emotions and their neural underpinnings SOCIETY FOR NEUROSCIENCE Researchers applied a machine learning technique that could potentially translate patterns of activity in fear-processing brain regions into scores on questionnaires used to assess a patient’s fear of pain. This neuroscientific approach, reported in eNeuro, may help reconcile self-reported emotions and their...

Post

Targeting kinetoplastid and apicomplexan thymidylate biosynthesis as antiprotozoal strategy

This article by Dr. Dolores Gonzalez Pacanowska et al. is published in Current Medicinal Chemistry, 2018 BENTHAM SCIENCE PUBLISHERS Kinetoplastid and apicomplexan parasites include protozoans which are responsible for human diseases, and cause a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic...

Post

GenMark Fungal Blood Culture Test Clears FDA

NEW YORK (GenomeWeb) – GenMark Diagnostics announced today it has received 510(k) clearance from the US Food and Drug Administration for a molecular diagnostic panel assay to detect fungal pathogens from blood cultures of patients with suspected blood stream infections. The test is called the ePlex Blood Culture Identification Fungal Pathogen (BCID-FP) Panel. It runs...